Stockreport
Amgen: Wait For A Better Entry Point (Rating Downgrade) [Seeking Alpha]
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
Their pipeline remains robust, with promising late-stage candidates like MariTide and upcoming study completions for Tepezza and Dazodalibep. Q4 financials show mixed results: strong key product sales offset by margin erosion and slowing overall growth; 2026 guidance implies further deceleration. Forward P/E has risen to 16.95, now near the multiyear high, making current levels unattractive for new entries despite long-term pipeline strength. JHVEPhoto/iStock Editorial via Getty Images Back in November 2025, I initiated coverage on Amgen Inc. ( AMGN ) with a buy rating. I viewed them as a cheap biotech leader as I saw strong sales growth, an impressive pipeline, and a This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation f
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | AMGN | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
AMGN alerts
AMGN alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
NEWS
NEWS
- Amgen declares $2.52 dividend [Seeking Alpha][Seeking Alpha]
- AMGEN ANNOUNCES 2026 SECOND QUARTER DIVIDEND[PR Newswire]
- Amgen Touts Broad Portfolio Momentum, MariTide Milestones and Repatha Access Push at TD Cowen Conf [Yahoo! Finance][Yahoo! Finance]
- Amgen Inc. (AMGN) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha][Seeking Alpha]
- Amgen Inc. (AMGN): A Bull Case Theory [Yahoo! Finance][Yahoo! Finance]
- More
AMGN
SEC Filings
SEC Filings
- 3/2/26 - Form 4
- 2/27/26 - Form 144
- 2/24/26 - Form 25-NSE
- AMGN's page on the SEC website
- More